PARADEEP2023-07-012023-09-30 PARADEEP2023-07-012023-09-30 PARADEEP2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member PARADEEP2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member PARADEEP2023-09-30 PARADEEP2023-07-012023-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PARADEEP2023-07-012023-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PARADEEP2023-07-012023-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PARADEEP2023-07-012023-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543530 PARADEEP NOTLISTED Paradeep Phosphates Limited Equity 2023-04-01 2024-03-31 2023-10-31 2023-10-19 INR Crores Half yearly 15:00:00 17:15:00 2023-10-31 2023-10-31 true Cash Flow Indirect Not applicable Single segment FERTILIZER 2023-07-01 2023-09-30 Unaudited Consolidated 36830200000.00 109900000.00 36940100000.00 20176900000.00 1548100000.00 7340200000.00 578100000.00 959400000.00 506800000.00 4626900000.00 35736400000.00 1203700000.00 0.00 1203700000.00 0.00 309400000.00 309400000.00 0.00 894300000.00 0.00 0.00 0.00 0.00 894300000.00 11000000.00 905300000.00 894300000.00 0.00 11000000.00 0.00 8147400000.00 10 1.10 1.10 0.00 0.00 1.10 1.10 0.01 0.00 0.01 Notes: 1. The above consolidated financial results were reviewed by the audit committee and approved by the Board of Directors in their respective meetings held on 31 October 2023. The limited review of these consolidated financial results, as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 has been completed by the statutory auditors of the Company. 2. Pursuant to the exercise of stock options by certain employees, the Company has allotted 2,41,834 equity shares during the period ended 30 September 2023 of Rs.10 each at exercise price per of Rs.42 per equity share. 3. The Company’s operations fall within a single business segment “Fertilisers and Other Trading Materials”. Hence, no separate segment information is disclosed. 4. Subsidy income for the period considers the impact of revised rates notified in accordance with the Nutrient Based Subsidy (NBS) Scheme by the Department of Fertilisers (DOF), Government of India on 26 October 2023. 5. On 1 June 2022, the Company completed the acquisition of Goa plant and allied business of Zuari Agro Chemicals Limited (ZACL) on a slump sale basis. The above financial results for the half year ended 30 September 2022 include the results of the acquired business for the period starting from 1 June 2022 and hence are not comparable with the other periods presented. Single segment 2023-04-01 2023-09-30 Unaudited Consolidated 67373500000.00 301700000.00 67675200000.00 44604900000.00 8318600000.00 1854900000.00 1160500000.00 1883000000.00 977000000.00 9260200000.00 68059100000.00 -383900000.00 0.00 -383900000.00 0.00 -84100000.00 -84100000.00 0.00 -299800000.00 0.00 0.00 0.00 5300000.00 -294500000.00 6400000.00 -288100000.00 -305100000.00 0.00 6400000.00 0.00 8147400000.00 10 -0.37 -0.37 0.00 0.00 -0.37 -0.37 0.01 0.00 0.01 Other Expenses 4626900000.00 Other Expenses 9260200000.00 32265300000.00 4367200000.00 0.00 580700000.00 19400000.00 0.00 0.00 31800000.00 0.00 0.00 0.00 0.00 0.00 549600000.00 555800000.00 38369800000.00 19255800000.00 0.00 26422000000.00 2352800000.00 909800000.00 0.00 3038300000.00 32722900000.00 0.00 5900100000.00 57878800000.00 2300000.00 0.00 96250900000.00 8147400000.00 26209800000.00 34357200000.00 34357200000.00 6111400000.00 0.00 200000.00 6111600000.00 243800000.00 994000000.00 0.00 0.00 7349400000.00 32904600000.00 16879000000.00 2714000000.00 52497600000.00 1303500000.00 740900000.00 2300000.00 0.00 54544300000.00 0.00 0.00 61893700000.00 96250900000.00 1631700000.00 3121000000.00 10474300000.00 0.00 0.00 0.00 0.00 917800000.00 0.00 0.00 0.00 -2528000000.00 0.00 977000000.00 0.00 -500000.00 0.00 0.00 0.00 168100000.00 0.00 31900000.00 6000000.00 0.00 -5300000.00 0.00 0.00 -72600000.00 0.00 14668200000.00 14284300000.00 0.00 0.00 0.00 566100000.00 0.00 13718200000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1600000.00 2180700000.00 10700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23100000.00 0.00 -242200000.00 0.00 -2387500000.00 0.00 0.00 10200000.00 0.00 0.00 0.00 0.00 0.00 106901900000.00 114592400000.00 0.00 9900000.00 0.00 1712700000.00 0.00 0.00 -9402900000.00 1927800000.00 0.00 1927800000.00 430300000.00 2358100000.00 Re-measurement gains/(losses) on defined benefit plans 14200000.00 Re-measurement gains/(losses) on defined benefit plans 1100000.00 14200000.00 1100000.00 3600000.00 300000.00 Exchange difference on translation of foreign operations 400000.00 Exchange difference on translation of foreign operations 5600000.00 400000.00 5600000.00 0.00 0.00